Xeris Biopharma Holdings, Inc.
NASDAQ:XERS · NASDAQ Global Select
+$0.04 today
Vol 1.95M · Avg 1.66M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+49.78%
Period High
$9.90
Period Low
$4.64
Latest
$6.95
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.49B
Celldex Therapeutics, Inc.
NASDAQ:CLDX
$2.19B
Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
$1.92B
BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRX
$1.90B
Sionna Therapeutics, Inc.
NASDAQ:SION
$1.67B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.65B
Immunocore Holdings plc
NASDAQ:IMCR
$1.45B
Biohaven Ltd.
NYSE:BHVN
$1.41B
Maze Therapeutics, Inc.
NASDAQ:MAZE
$1.38B
Janux Therapeutics, Inc.
NASDAQ:JANX
$842.43M
What is the latest XERS filing?
The latest filing shown is 8-K dated Jun 11, 2026.
How many recent filings does XERS have?
Intrinsic Alpha currently shows 20 recent filings for XERS.
Explore More
Continue the stock analysis
Jump to another research area for this company.